Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1346094
PUBLISHER: BCC Research | PRODUCT CODE: 1346094
Neurostimulation: Technologies and Global Markets
PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Highlights:
The global neurostimulation devices market should reach $11.7 billion by 2028 from $8.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028. Whereas the market was $7.7 billion in 2022 (base year).
Spinal cord stimulation devices segment of the global neurostimulation devices market is expected to grow from $2.6 billion in 2023 to $3.2 billion in 2028 at a CAGR of 4.2% for the forecast period of 2023 to 2028.
Hypoglossal nerve stimulation devices segment of the global neurostimulation devices market is expected to grow from $335.5 million in 2023 to $692.1 million in 2028 at a CAGR of 15.6% for the forecast period of 2023 to 2028.
Report Scope:
This report provides a comprehensive study of the global market for neurostimulation technologies and devices. It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.
Neurostimulation technologies and devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.
This report also covers in detail the therapeutic applications of neurostimulation technologies and devices, including chronic pain, Parkinson's disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.
Report Includes:
- 51 tables
- An overview of the global markets and technologies for neurostimulation
- Estimation of the market size and analyses of market trends, with data from 2020 to 2022, estimates for 2023 and projection of CAGR through 2028
- Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
- Detailed description of various types of stimulation such as spinal cord stimulation, transcutaneous electrical nerve stimulation, deep brain stimulation, sacral nerve stimulation, Vagus nerve stimulation, hypoglossal nerve stimulation, and transcranial magnetic stimulation; and discussion on their mode of action and advantages
- Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
- Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
- Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players of the industry, including Axonics Inc., Boston Scientific Corp., Medtronic PLC, Synapse Biomedical Inc. and Xavant Technology
Product Code: PHM149C
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing the Study
- What's New in This Update?
- Scope of Report
- Methodology and Information Sources
- Regional Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
Chapter 3 Market and Technology Background
- Overview of Neurostimulation
- Types of Neurostimulation Technologies
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation (SNS)
- Vagus Nerve Stimulation
- Hypoglossal Nerve Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation (TMS)
- Other Neurostimulation Technologies
- Therapeutic Applications for Neurostimulation
- Chronic Pain Management
- Neurological Disorders
- Urinary and Fecal Incontinence
- Obstructive Sleep Apnea
- Chronic Migraine and Headache
- Cardiovascular Diseases
- Gastrointestinal Disorders
- Obesity
- Psychiatric Disorders
- Technological Developments
- MRI Compatibility
- Rechargeable and Non-rechargeable Devices
Chapter 4 Market Dynamics
- Market Trends
- Drivers
- Market Restraints
Chapter 5 Market Breakdown by Technology/Device Type
- Global Market for Neurostimulation Devices by Type
- Spinal Cord Stimulation (SCS) Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- Deep Brain Stimulation (DBS) Devices
- Sacral Nerve Stimulation (SNS) Devices
- Vagus Nerve Stimulation (VNS) Devices
- Hypoglossal Nerve Stimulation (HGNS) Devices
- Market Size and Forecast
- Transcranial Magnetic Stimulation (TMS) Devices
- Other Types of Neurostimulation Devices
Chapter 6 Market Breakdown by Therapeutic Application
- Global Market for Neurostimulation Devices by Therapeutic Application
- Chronic Pain
- Urinary and Fecal Incontinence
- Parkinson's Disease
- Epilepsy
- Obstructive Sleep Apnea (OSA)
- Essential Tremor
- Major Depressive Disorder (MDD)/Clinical Depression
- Obsessive Compulsive Disorder (OCD)
- Other Therapeutic Applications
Chapter 7 Market Breakdown by Region
- Global Market for Neurostimulation Devices by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 8 Regulatory Structure
- Regulatory Framework
- U.S.
- European Union
- Japan
Chapter 9 Key Products and Technologies on the Market
- Recent Therapeutic Improvements and New Indications
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation (SNS)
- Axonics
- Medtronic
- Vagus Nerve Stimulation
- Hypoglossal Nerve Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Other Types of Stimulation
- New Indications and Neurostimulation Therapies
Chapter 10 Emerging Technologies and Developments
- Emerging Technologies and Developments
- Closed-Loop Neurostimulation
- Non-Invasive Brain Stimulation Techniques
- High-Frequency Stimulation
- Magnetic Resonance-guided Focused Ultrasound
- Optogenetics
- Bioelectronic Medicine
- Wireless and Remote-Controlled Devices
Chapter 11 Recent M&A
- M&A in the Neurostimulation Technologies Industry
Chapter 12 Competitive Landscape
- Company Market Shares by Product Segment
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Vagus Nerve Stimulation Devices
- Hypoglossal Nerve Stimulation Devices
- Transcranial Magnetic Stimulation Devices
- Transcutaneous Electrical Nerve Stimulation Devices
- Recent Industry Activities
Chapter 13 Company Profiles
- ABBOTT LABORATORIES
- ALEVA NEUROTHERAPEUTICS SA
- AVERY BIOMEDICAL DEVICES INC.
- AXONICS INC.
- BIOINDUCTION LTD.
- BIOVENTUS LLC
- BIOWAVE CORP.
- BOSTON SCIENTIFIC CORP.
- BRAINSWAY LTD.
- COCHLEAR AMERICAS
- CVRX INC.
- ELECTROCORE INC.
- INSPIRE MEDICAL SYSTEMS INC.
- INTEGER HOLDINGS CORP.
- LABORIE INC.
- LIVANOVA PLC
- MAG & MORE GMBH
- MAGSTIM INC.
- MEDTRONIC PLC
- NALU MEDICAL INC.
- NEUROMED CONSULTING INC.
- NEUROMETRIX INC.
- NEURONETICS INC.
- NEUROPACE INC.
- NEUROSIGMA INC.
- NEUROVALENS LTD.
- NEVRO CORP.
- NEXSTIM PLC
- NYXOAH SA
- SOTERIX MEDICAL INC.
- SYNAPSE BIOMEDICAL INC.
- XAVANT TECHNOLOGY (PTY) LTD.
- ZOLL MEDICAL CORP.
Chapter 14 Appendix: Acronyms
Product Code: PHM149C
List of Tables
- Summary Table : Global Market for Neurostimulation Devices, by Type, Through 2028
- Table 1 : Prevalence of Chronic Pain and High-Impact Chronic Pain Among U.S. Adults, by Sociodemographic Characteristics, 2016
- Table 2 : Type of Chronic Pain, U.S
- Table 3 : Prevalence of Adult Overweight and Obese Population, by Country, 2014-2022
- Table 4 : Global Market for Neurostimulation Devices, by Type, Through 2028
- Table 5 : Global Market for SCS Devices, by Region, Through 2028
- Table 6 : Global Market for TENS Devices, by Region, Through 2028
- Table 7 : Global Market for DBS Devices, by Region, Through 2028
- Table 8 : Global Market for SNS Devices, by Region, Through 2028
- Table 9 : Global Market for VNS Devices, by Region, Through 2028
- Table 10 : Global Market for HGNS Devices, by Region, Through 2028
- Table 11 : Global Market for TMS Devices, by Region, Through 2028
- Table 12 : Global Market for Other Types of Neurostimulation Devices, by Region, Through 2028
- Table 13 : Global Market for Neurostimulation Devices, by Therapeutic Application, Through 2028
- Table 14 : Global Market for Neurostimulation Devices, by Region, Through 2028
- Table 15 : Regulatory Approval: U.S. vs. Europe
- Table 16 : Implantable Neurostimulation Devices Approved, January 2018-May 2023
- Table 17 : Currently Available Spinal Cord Stimulation Systems
- Table 18 : Currently Available Deep Brain Stimulation Systems
- Table 19 : Currently Available Sacral Nerve Stimulation Systems
- Table 20 : Currently Available Vagus Nerve Stimulation Systems
- Table 21 : FDA-Approved TENS Systems for Pain Relief Treatment, 2015-2021
- Table 22 : FDA-Approved TENS Systems for Treatment of Migraine Pain Relief, 2015-2021
- Table 23 : Currently Available Phrenic Nerve Stimulation Systems for Respiratory Insufficiency
- Table 24 : Currently Available HGNS Systems for Respiratory Insufficiency
- Table 25 : Currently Available Peripheral Nerve Stimulation Systems
- Table 26 : Currently Available Transcranial Magnetic Stimulating Systems
- Table 27 : Currently Available Gastric Electrical Stimulation Systems
- Table 28 : Neurostimulation Stimulation Product Pipeline
- Table 29 : Active Clinical Trials on Spinal Cord Stimulation Technology
- Table 30 : Active Clinical Trials on DBS Technology
- Table 31 : Active Clinical Trials on VNS Technology
- Table 32 : Active Clinical Trials on Sacral Nerve Stimulation Technology
- Table 33 : Active Clinical Trials on Peripheral Nerve Stimulation Technology
- Table 34 : Active Clinical Trials on Hypoglossal Nerve Stimulation Technology
- Table 35 : Shares of Companies in the Global Market for SCS Devices, 2022
- Table 36 : Shares of Companies in the Market for DBS Devices, 2022
- Table 37 : Aleva Neurotherapeutics SA: News
- Table 38 : Axonics Inc.: Annual Revenue, 2022
- Table 39 : Axonics Inc.: News
- Table 40 : Axonics Inc.: Product Portfolio
- Table 41 : Bioventus LLC: Annual Revenue, 2022
- Table 42 : Bioventus LLC: News
- Table 43 : Bioventus LLC: Product Portfolio
- Table 44 : Boston Scientific Corp.: Annual Revenue, 2022
- Table 45 : Boston Scientific Corp.: News
- Table 46 : Boston Scientific Corp.: Product Portfolio
- Table 47 : Medtronic PLC: Annual Revenue, 2022
- Table 48 : Synapse Biomedical Inc.: News
- Table 49 : Xavant Technology: Product Portfolio
- Table 50 : Acronyms Used in This Report
List of Figures
- Summary Figure : Global Market for Neurostimulation Devices, by Type, 2020-2028
- Figure 1 : Global Market Shares of Neurostimulation Devices, by Type, 2022
- Figure 2 : Global Market for SCS Devices, by Region, 2020-2028
- Figure 3 : Global Market for TENS Devices, by Region, 2020-2028
- Figure 4 : Global Market for DBS Devices, by Region, 2020-2028
- Figure 5 : Global Market for SNS Devices, by Region, 2020-2028
- Figure 6 : Global Market for VNS Devices, by Region, 2020-2028
- Figure 7 : Global Market for HGNS Devices, by Region, 2020-2028
- Figure 8 : Global Market for TMS Devices, by Region, 2020-2028
- Figure 9 : Global Market for Other Types of Neurostimulation Devices, by Region, 2020-2028
- Figure 10 : Global Market Shares of Neurostimulation Devices, by Therapeutic Application, 2022
- Figure 11 : Global Market Shares of Neurostimulation Devices, by Region, 2022
- Figure 12 : Shares of Leading Companies in the Global Market for SCS Devices, 2022
- Figure 13 : Shares of Companies in the Market for DBS Devices, 2022
- Figure 14 : Abbott: Diagnostics Revenue, 2020-2022
- Figure 15 : Abbott: Diagnostics Market Share, by Business Segment, 2022
- Figure 16 : Abbott: Revenue Shares, by Business Unit, 2021
- Figure 17 : Abbott: Revenue Shares, by Market, 2021
- Figure 18 : Axonics Inc.: Annual Revenue, 2021 and 2022
- Figure 19 : Axonics Inc.: Revenue Shares, by Business Unit, 2022
- Figure 20 : Axonics Inc.: Revenue Shares, by Country/Region, 2022
- Figure 21 : Bioventus LLC: Annual Revenue, 2021 and 2022
- Figure 22 : Bioventus LLC: Revenue Shares, by Business Unit, 2022
- Figure 23 : Bioventus LLC: Revenue Shares, by Country/Region, 2022
- Figure 24 : Boston Scientific Corp.: Annual Revenue, 2021 and 2022
- Figure 25 : Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
- Figure 26 : Boston Scientific Corp.: Revenue Shares, by Country/Region, 2022
- Figure 27 : Medtronic PLC: Annual Revenue, 2021 and 2022
- Figure 28 : Medtronic PLC: Revenue Shares, by Business Unit, 2022
- Figure 29 : Medtronic PLC: Revenue Shares, by Country/Region, FY2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.